Ontology type: schema:ScholarlyArticle
2014-12
AUTHORSYoleen P. M. Van Camp, Bernard Vrijens, Ivo Abraham, Bart Van Rompaey, Monique M. Elseviers
ABSTRACTBACKGROUND: Phosphate control is a crucial treatment goal in end-stage renal disease, but poor patient adherence to phosphate binder therapy remains a challenge. This study aimed to estimate the extent of phosphate binder adherence in hemodialysis patients and to identify potential determinants. METHODS: Phosphate binder adherence was measured blindly in 135 hemodialysis patients for 2 months using the medication event monitoring system. Patient data, gathered at inclusion through medical records, ad hoc questionnaires and the short form (SF)-36 health survey, included: (1) demographics, (2) perceived side-effects, belief in benefit, self-reported adherence to the therapy, (3) knowledge about phosphate binder therapy, (4) social support, and (5) quality of life (SF-36). Phosphatemia data was collected from charts. 'Being adherent' was defined as missing <1 total daily dose/week and 'being totally adherent' as missing <1 total daily dose/week, every week. RESULTS: Mean age of patients was 67 years and 64 % of the sample was male. Over the 2 months, 78 % of the prescribed doses were taken. Every week, about half of patients were adherent. Over the entire 8-week period, 22 % of patients were totally adherent. Mean phosphatemia levels were 0.55 mg/dl lower in adherent than nonadherent patients (4.76 vs. 5.31 mg/dl). Determinants for being totally adherent were living with a partner, higher social support (both were interrelated) and higher physical quality of life. Experiencing intake-related inconvenience negatively affected adherence. The social support and quality of life physical score explained 26 % of the variance in adherence. CONCLUSIONS: Phosphate binder nonadherence remains a major problem. Interventions should aim, at least, to improve social support. With few associated factors found and yet low adherence, an individualized approach seems indicated. More... »
PAGES673-679
http://scigraph.springernature.com/pub.10.1007/s40620-014-0062-3
DOIhttp://dx.doi.org/10.1007/s40620-014-0062-3
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1022149309
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/24563270
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Public Health and Health Services",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged, 80 and over",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Belgium",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Chelating Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Hyperphosphatemia",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Kidney Failure, Chronic",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Patient Compliance",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Phosphates",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Quality of Life",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Renal Dialysis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Social Support",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Surveys and Questionnaires",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Time Factors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "University of Antwerp",
"id": "https://www.grid.ac/institutes/grid.5284.b",
"name": [
"Faculty of Medicine and Health Sciences, Centre for Research and Innovation in Care (CRIC), Universiteit Antwerpen, CDE R334, Universiteitsplein 1, 2610, Wilrijk, Belgium"
],
"type": "Organization"
},
"familyName": "Van Camp",
"givenName": "Yoleen P. M.",
"id": "sg:person.0607624365.72",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607624365.72"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Li\u00e8ge",
"id": "https://www.grid.ac/institutes/grid.4861.b",
"name": [
"Department of Biostatistics and Medical Informatics, Universit\u00e9 de Li\u00e8ge, Li\u00e8ge, Belgium",
"MWV Healthcare, Vis\u00e9, Belgium"
],
"type": "Organization"
},
"familyName": "Vrijens",
"givenName": "Bernard",
"id": "sg:person.0732226413.07",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732226413.07"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Arizona",
"id": "https://www.grid.ac/institutes/grid.134563.6",
"name": [
"Center for Health Outcomes and Pharmacoeconomic Research (HOPE), University of Arizona, Tucson, AZ, USA"
],
"type": "Organization"
},
"familyName": "Abraham",
"givenName": "Ivo",
"id": "sg:person.01237717473.45",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237717473.45"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Artesis Plantijn Hogeschool Antwerpen",
"id": "https://www.grid.ac/institutes/grid.454226.3",
"name": [
"Faculty of Medicine and Health Sciences, Centre for Research and Innovation in Care (CRIC), Universiteit Antwerpen, CDE R334, Universiteitsplein 1, 2610, Wilrijk, Belgium",
"Department of Healthcare, Artesis University College of Antwerp, Antwerp, Belgium"
],
"type": "Organization"
},
"familyName": "Van Rompaey",
"givenName": "Bart",
"id": "sg:person.01204647621.55",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204647621.55"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Antwerp",
"id": "https://www.grid.ac/institutes/grid.5284.b",
"name": [
"Faculty of Medicine and Health Sciences, Centre for Research and Innovation in Care (CRIC), Universiteit Antwerpen, CDE R334, Universiteitsplein 1, 2610, Wilrijk, Belgium"
],
"type": "Organization"
},
"familyName": "Elseviers",
"givenName": "Monique M.",
"id": "sg:person.01133122750.93",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133122750.93"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/ki.2008.644",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1001414143",
"https://doi.org/10.1038/ki.2008.644"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/1471-2369-9-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1001943039",
"https://doi.org/10.1186/1471-2369-9-2"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmra050100",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1004833991"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmra050100",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1004833991"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1365-2125.2012.04167.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006076798"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00228-012-1419-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010686337",
"https://doi.org/10.1007/s00228-012-1419-y"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1053/j.ajkd.2010.03.002",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017310635"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1476-5381.2008.00108.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017707857"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1476-5381.2008.00108.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017707857"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1159/000329106",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019137081"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/ndt/gfn310",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028799432"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/2047-783x-14-5-185",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1030730848",
"https://doi.org/10.1186/2047-783x-14-5-185"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/ndt/gfq219",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031147030"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0895-4356(98)00097-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1041396432"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/ki.2009.60",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1042936786",
"https://doi.org/10.1038/ki.2009.60"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11096-008-9212-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048816378",
"https://doi.org/10.1007/s11096-008-9212-9"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1744-9987.2012.01098.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051395693"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.5414/cnp72199",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1072833665"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1078043198",
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.7334/psicothema2012.96",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1078677412"
],
"type": "CreativeWork"
}
],
"datePublished": "2014-12",
"datePublishedReg": "2014-12-01",
"description": "BACKGROUND: Phosphate control is a crucial treatment goal in end-stage renal disease, but poor patient adherence to phosphate binder therapy remains a challenge. This study aimed to estimate the extent of phosphate binder adherence in hemodialysis patients and to identify potential determinants.\nMETHODS: Phosphate binder adherence was measured blindly in 135 hemodialysis patients for 2 months using the medication event monitoring system. Patient data, gathered at inclusion through medical records, ad hoc questionnaires and the short form (SF)-36 health survey, included: (1) demographics, (2) perceived side-effects, belief in benefit, self-reported adherence to the therapy, (3) knowledge about phosphate binder therapy, (4) social support, and (5) quality of life (SF-36). Phosphatemia data was collected from charts. 'Being adherent' was defined as missing <1 total daily dose/week and 'being totally adherent' as missing <1 total daily dose/week, every week.\nRESULTS: Mean age of patients was 67 years and 64 % of the sample was male. Over the 2 months, 78 % of the prescribed doses were taken. Every week, about half of patients were adherent. Over the entire 8-week period, 22 % of patients were totally adherent. Mean phosphatemia levels were 0.55 mg/dl lower in adherent than nonadherent patients (4.76 vs. 5.31 mg/dl). Determinants for being totally adherent were living with a partner, higher social support (both were interrelated) and higher physical quality of life. Experiencing intake-related inconvenience negatively affected adherence. The social support and quality of life physical score explained 26 % of the variance in adherence.\nCONCLUSIONS: Phosphate binder nonadherence remains a major problem. Interventions should aim, at least, to improve social support. With few associated factors found and yet low adherence, an individualized approach seems indicated.",
"genre": "research_article",
"id": "sg:pub.10.1007/s40620-014-0062-3",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1100597",
"issn": [
"1121-8428",
"1724-6059"
],
"name": "Journal of Nephrology",
"type": "Periodical"
},
{
"issueNumber": "6",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "27"
}
],
"name": "Adherence to phosphate binders in hemodialysis patients: prevalence and determinants",
"pagination": "673-679",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"69865babfa961a13b67ec93598151bfced95ffdd2b346e2cfd4381249ad66062"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"24563270"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"9012268"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s40620-014-0062-3"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1022149309"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s40620-014-0062-3",
"https://app.dimensions.ai/details/publication/pub.1022149309"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-10T15:56",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000536.jsonl",
"type": "ScholarlyArticle",
"url": "http://link.springer.com/10.1007%2Fs40620-014-0062-3"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40620-014-0062-3'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40620-014-0062-3'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40620-014-0062-3'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40620-014-0062-3'
This table displays all metadata directly associated to this object as RDF triples.
243 TRIPLES
21 PREDICATES
66 URIs
40 LITERALS
28 BLANK NODES